Report Categories
View AllRecent Articles
View All
VRDN Viridian Therapeutics notches narrow Q4 2025 EPS beat but shares fall 358 percent on lukewarm investor sentiment
THW abrdn quarterly earnings reflect managements optimistic longterm outlook for global healthcare investment opportunities
PRI Primerica reports 69 EPS beat for Q4 2025 stock slips 03 in todays trading